Eur. Urol. 2013 Mar 26
Personalizing the management of men with intermediate-risk prostate cancer.
Related Questions
New comment by Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School ( January 5, 2022)
Very interesting and clinically important question. The risk stratification strategy based on clinical features (Gleason score, PSA, and Rectal exam) really does not reflect t...